Pharma channel feed – Endpoints News

Pharma channel feed

With new RSV antibody, Sanofi looks to avoid a repeat of a 20-year-old pricing controversy

4 years ago

Government watchdog questions Eli Lilly's campaign contributions

4 years ago

Novartis, Eli Lilly and AbbVie join growing list of Big Pharmas severing ties with Russia

4 years ago

Cytiva opens doors at Cardiff site as part of $1.5B global expansion

4 years ago

Kansas court preliminarily approves Viatris' $264M EpiPen settlement

4 years ago

MarketingRx roundup: Pfizer’s CEO talks pandemic pressure at SXSW; Exact Sciences teams with Katie Couric for screening

4 years ago

Ovid joins the restructuring movement, laying off staff as Jeremy Levin's crew refocuses on epilepsy

4 years ago

Eisai finds an exit from Aduhelm, with small royalties if it ever nabs coverage

4 years ago

Alzheimer’s group amps public pressure with ad campaign as Medicare decision looms

4 years ago

As Sandoz waits for Novartis to determine its fate, the generics player buys out a respiratory device company

4 years ago

GreenLight licenses mRNA shingles vaccine to Serum Institute following a $10M investment

4 years ago

House committee calls on DOJ to investigate companies' opioid settlement tax benefits

4 years ago

Appeals court sides with Bristol Myers Squibb in years-long battle with investors over Opdivo fail

4 years ago

Grassley to FTC: Investigate the role of PBMs on out-of-pocket costs

4 years ago

No more business as usual: Pfizer, Bayer and Sanofi step up actions against Russia amid growing pressure to exit

4 years ago

GMP-in-a-box company with Bob Nelsen backing lands $167M to develop its own cancer drugs

4 years ago

Moving up the treatment lines, AstraZeneca clinches adjuvant breast cancer OK for Lynparza

4 years ago

FDA hits back Fasenra in key rhinosinusitis field, putting AstraZeneca even further behind Big Pharma rivals

4 years ago

Fresenius centers its own March madness on kidney campaign with former NBA star and kidney transplant patient

4 years ago

Following Vraylar success, AbbVie extends partnership with Gedeon Richter to neuropsychiatric diseases

4 years ago

More inspection trouble for Zydus just a day after big acquisition

4 years ago

Senators call on CMS to finalize pharmacy fee reforms to save seniors $21B in out-of-pocket expenses

4 years ago

US-funded Phlow's first round of essential generics headed to children's hospitals, but they're made with foreign APIs

4 years ago

Novavax aims for name recognition in new vaccines campaign

4 years ago

First page Previous page 216 217 218219220 221 222 Next page Last page